Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05793593 · ClinicalTrials.gov registry record · NA

A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer

A NA study of Colon Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
80
Enrollment target
7
Study locations

NCT05793593 is a NA study of Colon Cancer Screening that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 80 participants, below the 588-participant average among 4 other Colon Cancer Screening trials with a reported enrollment target (86% lower). The trial reports 7 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05793593, a NA study of Colon Cancer Screening, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
7
Study locations

Study Summary

The Black community has higher rates of colorectal cancer and lower rates of colorectal cancer screenings than whites. Getting screened through FIT testing may help catch colorectal cancer earlier, when it is easier to treat. MSK has created a program to help people who have been FIT tested to also help their peers (family, friends, and colleagues) in their community get FIT tested. The researchers think that training people on peer outreach, such as telling people in your social network about FIT testing and how to get it, may increase the rate of colorectal cancer screening. The purpose of this study is to see if training people on peer outreach increases the number of people who get screened for colorectal cancer through FIT testing.

Conditions Studied

Interventions

  • OTHER FITx3 intervention and CRC education
  • OTHER Colorectal Cancer (CRC) education alone

Study Locations (7)

New York

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (All Protocol Activities) - Rockville Centre

New Jersey

  • Memoiral Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-03-17
Est. Completion 2026-03
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT05793593

The ClinicalTrials.gov registry entry for NCT05793593 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 588-participant average among 4 other Colon Cancer Screening trials with a reported enrollment target (86% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colon Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which FITx3 intervention and CRC education is the first listed.

NCT05793593 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05793593 about?

NCT05793593 is a clinical study titled "A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer". The Black community has higher rates of colorectal cancer and lower rates of colorectal cancer screenings than whites. Getting screened through FIT testing may help catch colorectal cancer earlier, when it is easier to treat. MSK has created a program to help people who have been FIT tested to also ...

What is the current status of trial NCT05793593?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-03-17. Estimated completion is 2026-03.

What conditions does trial NCT05793593 study?

This clinical trial studies the following conditions: Colon Cancer Screening.

What interventions are being tested in trial NCT05793593?

The interventions under investigation include: FITx3 intervention and CRC education (OTHER), Colorectal Cancer (CRC) education alone (OTHER).

Who is sponsoring clinical trial NCT05793593?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05793593 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colon Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.